DYN vs LYFT · $1.19B cap vs P/E 108, rev $5.79B
Dyne Therapeutics Inc (DYN) versus LYFT Inc (LYFT) — a side-by-side from cached financials, not a winner call.
Dyne Therapeutics Inc (DYN) is a biotechnology company listed on US.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
DYN does not have a complete income-statement cache yet.
Latest reported LYFT revenue for 2024-12-31 was $5.79B. Net income was $22.8M. Revenue was up 31.4% from 2023-12-31 to 2024-12-31. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
DYN currently screens at market cap $1.19B. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
Not investment advice. Open the DYN and LYFT stock pages for the full models.
Not investment advice.